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Figure S1. HPLC-HREIMS spectra of marchantin A 
Conditions: Agilent 1100 system consisting of degasser, quaternary pump, auto sampler, 
column oven, photodiode array detector (PDA) and a 150 × 4.6 mm Phenomenex C18 Luna 
column with particle size of 5 µm and pore size of 100 Å (Phenomenex, Inc., Torrance, CA). 
The column was operated at 40 °C. Solvent was delivered at 0.5 ml/min using the following 
linear gradient elution profile: 50% B to 100% B over 30 min (solvent A: water/acetonitrile 95:5 
+ 0.1% formic acid; solvent B: acetonitrile/water 95:5 + 0.1% formic acid). The flow from the 
column was split by a T-piece connected to capillaries of different length and i.d. (10 cm/0.05 
µm, 100 cm/0.5 µm), directing < 1% of the column outflow to a micrOTOF-Q mass 
spectrometer equipped with electrospray ionization (ESI) interface (Bruker Daltonik GmbH, 
Bremen, Germany). Mass spectra were acquired in positive-ion mode, using drying temperature 


























































Figure S6. The structure of marchantin A 
 
3 marchantin A           
Sample Name: marchantin A 
  
Injection Volume: 10,0   





Sample Type: unknown 
  
Wavelength: 210 
Control Program: marchantin 70-30 
  
Bandwidth: 1 





Recording Time: 7.4.2011 11:09 
   




       
        
        
        No.  Ret.Time  Peak Name  Height  Area  Rel.Area  Amount  Type  
  min   mAU mAU*min %     
1   5,37       n.a. 0,190  0,022  0,00     n.a. BMB 
2   5,94       n.a. 0,110  0,032  0,00     n.a. BMB 
3   6,81       n.a. 0,569  0,246  0,02     n.a. BM  
4   7,03       n.a. 0,492  0,175  0,01     n.a.  M  
5   7,56       n.a. 0,152  0,019  0,00     n.a.  MB 
6   8,10       n.a. 8,890  3,025  0,22     n.a. BMB 
7   9,09       n.a. 0,196  0,017  0,00     n.a. BMB 
8   9,78       n.a. 0,083  0,006  0,00     n.a. BMB 
9   10,95       n.a. 0,111  0,017  0,00     n.a. BM  
10   11,20       n.a. 0,245  0,027  0,00     n.a.  M  
11   11,64       n.a. 0,046  0,008  0,00     n.a. Ru 
12   12,42       n.a. 5,714  3,927  0,29     n.a.  M  
13   14,18       n.a. 69,678  36,061  2,67     n.a.  M  
14   15,94       Marchantin A 2376,367  1303,206  96,40     n.a.  M  
15   21,68       n.a. 0,067  0,005  0,00     n.a. Ru 
16   21,91       n.a. 0,060  0,005  0,00     n.a. Ru 
 





MARCHANTIN A #3 Marchantin A UV_VIS_1
mAU
min
14 - Marchantin A
WVL:210 nm
 
17   22,11       n.a. 1,447  2,778  0,21     n.a.  M  
18   22,33       n.a. 0,086  0,007  0,00     n.a. Rd 
19   22,60       n.a. 0,098  0,016  0,00     n.a. Rd 
20   23,07       n.a. 0,181  0,023  0,00     n.a. Rd 
21   24,00       n.a. 0,040  0,005  0,00     n.a. Ru 
22   24,15       n.a. 0,965  1,525  0,11     n.a.  M  
23   25,01       n.a. 0,090  0,022  0,00     n.a. Rd 
24   25,59       n.a. 0,081  0,007  0,00     n.a. Rd 
25   26,17       n.a. 0,138  0,024  0,00     n.a. Rd 
26   26,48       n.a. 0,466  0,121  0,01     n.a.  M  
27   26,78       n.a. 0,399  0,171  0,01     n.a.  M  
28   27,33       n.a. 0,317  0,151  0,01     n.a.  M  
29   27,98       n.a. 0,204  0,038  0,00     n.a.  M  
30   28,26       n.a. 0,169  0,021  0,00     n.a.  M  
Total:     2468,111  1351,821  100,00     0,000    













































































































































































Table S1.  



















7.02 dd 7.33 dd 7.32 dd 7.32 dd 7.33 dd 7.33 dd 7.33 dd 7.33 dd 
11 
7.15 t 7.19 t 7.20 t 7.20 t 7.21 t 7.21 t 7.21 t 7.21 t 
12 
6.87 dd 6.99 dd 6.99 dd 6.99 dd 6.99 dd 6.99 dd 6.99 dd 6.99 dd 
3' 
5.14 d 5.21 d 5.21 d 5.19 d 5.19 d 5.58 d 5.58 d 5.56 d 
5' 
6.48 d 6.46 d 6.46 d 6.45 d 6.46 d 6.65 d 6.64 d 6.64 d 
*bolded chemical shifts – shifts changed after esterification 
 
Table S2.  


















1' 132.4 130.6 130.7 130.6 130.6 129.9 130.0 130.0 
2' 146.3 146.1 146.2 146.1 146.2 151.5 151.5 151.5 
3' 107.7 107.8 107.9 107.8 107.8 114.0 114.0 114.0 
4' 130.6 130.6 130.7 130.6 130.6 138.6 138.6 138.6 
5' 109.1 109.3 109.3 109.3 109.3 115.9 115.9 115.9 
6' 144.1 144.1 144.2 144.1 144.1 143.0 143.0 143.1 
9 136.0 136.6 136.6 136.6 136.6 136.6 136.7 136.7 
10 121.8 128.1 128.1 128.1 128.1 128.1 128.1 128.1 
11 126.0 124.6 124.7 124.7 124.7 124.7 124.7 124.7 
12 114.3 121.7 121.6 121.6 121.6 121.6 121.6 121.6 
13 148.7 142.5 142.5 142.6 142.6 142.4 142.6 142.6 
14 139.6 144.0 144.0 144.0 144.0 143.8 143.9 143.9 










Table S3. Calculated of physically significant molecular descriptors and 
pharmaceutically relevant properties. 
molecule #rotor mol_MW SASA FOSA FISA volume IP(eV) 
MA 13 440.495 631.316 145.975 137.602 1239.139 8.784 
ME1 14 496.559 649.011 207.825 97.371 1365.938 8.885 
ME2 15 510.585 680.004 231.146 102.412 1410.856 8.865 
ME3 17 538.639 738.305 304.435 136.256 1535.528 8.851 
ME4 19 566.693 776.503 354.667 130.893 1624.729 8.937 
TE1 16 608.687 858.112 459.822 102.712 1757.838 9.136 
TE2 19 650.767 903.729 526.842 86.342 1890.078 9.089 
TE3 25 734.928 903.146 533.443 90.259 2064.331 9.354 
 

















MA 38.41 13.869 19.013 4.747 -8.054 490.926 229.285 -1.582 
ME1 42.805 14.454 20.423 5.384 -8.675 1181.756 592.576 -0.759 
ME2 43.986 14.84 20.737 5.623 -8.963 1058.592 526.113 -0.746 
ME3 47.224 15.758 21.562 6.108 -9.541 505.572 236.687 -1.35 
ME4 49.446 16.421 22.059 6.699 -10.121 568.381 268.624 -1.083 
TE1 56.744 17.073 23.487 6.259 -9.495 1051.67 522.395 -0.835 
TE2 60.062 18.024 24.496 7.229 -10.389 1503.569 768.775 -0.263 
TE3 63.077 18.964 25.901 8.326 -12.176 1380.287 700.875 0.202 
 
List of QikProp properties and descriptors. 
#rotor Number of non-trivial (not CX3), non-hindered (not alkene, amide, small ring) rotatable 
bonds. 
mol_MW Molecular weight of the molecule. 
SASA Total solvent accessible surface area (SASA) in square angstroms using a probe with a 1.4 Å 
radius. 
FOSA Hydrophobic component of the SASA (saturated carbon and attached hydrogen). 
FISA Hydrophilic component of the SASA (SASA on N, O, H on heteroatoms, carbonyl C). 
Volume Total solvent-accessible volume in cubic angstroms using a probe with a 1.4 Å radius. 
IP(ev) PM3 calculated ionization potential (negative of HOMO energy). 
QPpolrz Predicted polarizability in cubic angstroms.  
QPlogPC16 Predicted hexadecane/gas partition coefficient. 
QPlogPoct Predicted octanol/gas partition coefficient. 
QPlogPw Predicted water/gas partition coefficient. 
QPlogPo/w Predicted octanol/water partition coefficient. 
CIQPlogS Conformation-independent predicted aqueous solubility, log S. S in mol dm
−3
 is the 
concentration of the solute in a saturated solution that is in equilibrium with the crystalline solid. 
QPPCaco Predicted apparent Caco-2 cell permeability in nm/sec. Caco-2 cells are a model for 
the gut-blood barrier. QikProp predictions are for non-active transport. 
QPPMDCK Predicted apparent MDCK cell permeability in nm/sec. MDCK cells are considered to 
be a good mimic for the blood-brain barrier. QikProp predictions are for non-active transport. 
QPlogKp Predicted skin permeability, log 
 
